{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ustekinumab+90+mg&page=2", "query": { "intervention": "ustekinumab 90 mg", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 42, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ustekinumab+90+mg&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ustekinumab+90+mg&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-04T13:03:18.785Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01077362", "title": "A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Arthritis, Psoriatic" ], "interventions": [ { "name": "placebo", "type": "DRUG" }, { "name": "ustekinumab 45 mg", "type": "DRUG" }, { "name": "ustekinumab 90 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 312, "start_date": "2010-03", "completion_date": "2012-11", "has_results": true, "last_update_posted_date": "2014-02-27", "last_synced_at": "2026-10-04T13:03:18.785Z", "location_count": 25, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Los Angeles, California + 22 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01077362" }, { "nct_id": "NCT00265122", "title": "A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Crohn Disease" ], "interventions": [ { "name": "Ustekinumab 90 mg", "type": "DRUG" }, { "name": "Ustekinumab 4.5 mg/kg", "type": "DRUG" }, { "name": "Placebo SC", "type": "DRUG" }, { "name": "Placebo IV", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Centocor, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 131, "start_date": "2004-04", "completion_date": "2006-10", "has_results": true, "last_update_posted_date": "2014-02-13", "last_synced_at": "2026-10-04T13:03:18.785Z", "location_count": 50, "location_summary": "Scottsdale, Arizona • Anaheim, California • Sacramento, California + 47 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Bristol", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00265122" }, { "nct_id": "NCT01645280", "title": "A Study of the Effectiveness and Safety of Ustekinumab (STELARA) and CNTO 1959 Administered Under the Skin of Patients With Active Rheumatoid Arthritis, Despite Existing Methotrexate Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Arthritis, Rheumatoid" ], "interventions": [ { "name": "Placebo + methotrexate (MTX) (Group 1)", "type": "DRUG" }, { "name": "Ustekinumab + MTX (Group 2)", "type": "DRUG" }, { "name": "Ustekinumab + MTX (Group 3)", "type": "DRUG" }, { "name": "CNTO 1959 + MTX (Group 4)", "type": "DRUG" }, { "name": "CNTO 1959 + MTX (Group 5)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 274, "start_date": "2012-08", "completion_date": "2014-05", "has_results": true, "last_update_posted_date": "2016-05-12", "last_synced_at": "2026-10-04T13:03:18.785Z", "location_count": 3, "location_summary": "Palm Harbor, Florida • Rock Island, Illinois • St Louis, Missouri", "locations": [ { "city": "Palm Harbor", "state": "Florida" }, { "city": "Rock Island", "state": "Illinois" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01645280" }, { "nct_id": "NCT01999868", "title": "Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "Ustekinumab", "type": "BIOLOGICAL" }, { "name": "Abatacept", "type": "BIOLOGICAL" }, { "name": "UST Placebo", "type": "DRUG" }, { "name": "ABA Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 108, "start_date": "2014-03-19", "completion_date": "2018-03-01", "has_results": true, "last_update_posted_date": "2019-01-15", "last_synced_at": "2026-10-04T13:03:18.785Z", "location_count": 8, "location_summary": "Los Angeles, California • Chicago, Illinois • New Orleans, Louisiana + 5 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01999868" }, { "nct_id": "NCT00267969", "title": "A Study of Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "ustekinumab", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Centocor Research & Development, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 766, "start_date": "2005-12", "completion_date": "2011-05", "has_results": true, "last_update_posted_date": "2013-06-17", "last_synced_at": "2026-10-04T13:03:18.785Z", "location_count": 28, "location_summary": "Phoenix, Arizona • Los Angeles, California • Redwood City, California + 25 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Redwood City", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00267969" }, { "nct_id": "NCT02877134", "title": "Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Crohn Disease" ], "interventions": [ { "name": "JNJ-64304500", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Ustekinumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 388, "start_date": "2016-08-25", "completion_date": "2022-01-24", "has_results": true, "last_update_posted_date": "2025-04-29", "last_synced_at": "2026-10-04T13:03:18.785Z", "location_count": 37, "location_summary": "Lone Tree, Colorado • Coral Gables, Florida • Kissimmee, Florida + 34 more", "locations": [ { "city": "Lone Tree", "state": "Colorado" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Kissimmee", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miramar", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02877134" }, { "nct_id": "NCT05335356", "title": "Comparing Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Moderate to Severe Chronic Plaque Psoriasis" ], "interventions": [ { "name": "Stelara", "type": "BIOLOGICAL" }, { "name": "Bmab1200", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Biocon Biologics UK Ltd", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 384, "start_date": "2022-06-28", "completion_date": "2023-11-15", "has_results": true, "last_update_posted_date": "2025-09-12", "last_synced_at": "2026-10-04T13:03:18.785Z", "location_count": 1, "location_summary": "Mayfield Heights, Ohio", "locations": [ { "city": "Mayfield Heights", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05335356" }, { "nct_id": "NCT02349061", "title": "A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lupus Erythematosus, Systemic" ], "interventions": [ { "name": "Ustekinumab IV", "type": "DRUG" }, { "name": "Placebo Infusion", "type": "DRUG" }, { "name": "Placebo SC", "type": "DRUG" }, { "name": "Ustekinumab SC", "type": "DRUG" }, { "name": "Concomitant Medication", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 102, "start_date": "2015-10-15", "completion_date": "2019-03-13", "has_results": true, "last_update_posted_date": "2020-03-24", "last_synced_at": "2026-10-04T13:03:18.785Z", "location_count": 12, "location_summary": "Huntsville, Alabama • Beverly Hills, California • Tampa, Florida + 9 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Lansing", "state": "Michigan" }, { "city": "Manhasset", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02349061" }, { "nct_id": "NCT00771667", "title": "A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "Placebo (IP)", "type": "DRUG" }, { "name": "Ustekinumab 1mg/kg (IP)", "type": "DRUG" }, { "name": "Ustekinumab 3 mg/kg (IP)", "type": "DRUG" }, { "name": "Ustekinumab 6 mg/kg (IP)", "type": "DRUG" }, { "name": "Placebo IV - Responder - Placebo SC (MP)", "type": "DRUG" }, { "name": "Placebo IV - Nonresponder - Ustekinumab 270/90 mg SC (MP)", "type": "DRUG" }, { "name": "Ustekinumab IV - Responder - Placebo SC (MP)", "type": "DRUG" }, { "name": "Ustekinumab IV - Responder - Ustekinumab 90mg SC (MP)", "type": "DRUG" }, { "name": "Ustekinumab IV - Nonresponder - Placebo SC (MP)", "type": "DRUG" }, { "name": "Ustekinumab IV - Nonresponder - Ustekinumab 90mg SC (MP)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Centocor, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 526, "start_date": "2008-12", "completion_date": "2010-12", "has_results": true, "last_update_posted_date": "2013-04-01", "last_synced_at": "2026-10-04T13:03:18.785Z", "location_count": 88, "location_summary": "Mobile, Alabama • Scottsdale, Arizona • La Jolla, California + 85 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Roseville", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00771667" }, { "nct_id": "NCT01389973", "title": "A Study of Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic Acid", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Primary Biliary Cirrhosis" ], "interventions": [ { "name": "ustekinumab 90 mg", "type": "DRUG" }, { "name": "ustekinumab 45 mg", "type": "DRUG" }, { "name": "ustekinumab 180 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 20, "start_date": "2011-09", "completion_date": "2013-06", "has_results": true, "last_update_posted_date": "2016-06-20", "last_synced_at": "2026-10-04T13:03:18.785Z", "location_count": 6, "location_summary": "Jacksonville, Florida • Miami, Florida • Naples, Florida + 3 more", "locations": [ { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Naples", "state": "Florida" }, { "city": "Tupelo", "state": "Mississippi" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01389973" } ] }